-
July 28, 2010 Lupin Net Profit up by 40 % in Q1, FY 2010-11 Consistent Growth, Strong Profits
-
July 1, 2010 Lupin receives FDA approval for Famotidine for Oral Suspension
-
June 4, 2010 Lupin receives FDA approval for Lamotrigine tablets
-
May 5, 2010 Lupin FY 2009-10 Consolidated Net Profits up 36% to Rs 6816 mn
-
April 20, 2010 Lupin receives FDA approval for Imipramine Pamoate Capsules
-
March 25, 2010 Lupin launches Hyalgan® in India Marks foray into the Orthopaedics segment
-
March 20, 2010 Lupin receives FDA tentative approval for Eszopiclone tablets
-
February 8, 2010 Lupin receives US FDA approval for Amlodipine / Benazepril capsules
-
January 29, 2010 Lupin Net Profit up 38 % – Q3, FY 2009-10
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications